 |
|
|
Overview
The Canadian Foundation on Fetal Alcohol
Research (CFFAR) is a new funding agency aimed at supporting
research on the fetal effects of alcohol.
CFFAR supports research into all aspects of
Fetal Alcohol Spectrum Disorder (FASD). The Scientific Review
Committee adjudicates research grant applications submitted
from all parts of Canada.
Researchers may obtain a maximum of $40,000
annually for a maximum of two years to support research projects
related to the fetal effects of alcohol.
CFFAR grant applicants will be required to
secure matching support for the proposed project from academic,
community or public agency sources. Matching support may be cash
or in kind (e.g., laboratory facilities, administrative support,
etc).
Eligibility
-
Applications may be submitted by
public or private non-profit organizations such as
universities, colleges, hospitals, research institutes,
government research agencies and laboratories in Canada. Grants are
only made to institutions on behalf of a named principal
investigator, not to individuals.
-
Priority will be given to young
investigators. It is recommended that young investigators
team up with senior investigators whenever possible and
realistic.
-
The proposed principal investigator of
the research project must be a faculty or staff member of
the applicant institution. This person must be qualified to
direct the research and is responsible for its conduct.
-
Trainees, such as undergraduate,
graduate or medical students, postdoctoral fellows, interns
and residents, are not eligible to serve as principal
investigators, unless they will be in independent faculty
positions, or the equivalent, at the start of the grant
period.
Application Process
In order to qualify for an annual CFFAR grant,
applicants must submit a
Letter of Intent by e-mail to:
researchgrants@fasdfoundation.ca.
-
The Letter of Intent must be received by
5:00 pm (EST) on December 31 of each year or the following
business day if the 31st falls on a weekend.
-
The
Letter of Intent must be 2 pages
maximum and follow the outline proposed in the document. Letters of Intent that exceed the
2 page limit will not be accepted.
-
If the Letter of Intent is accepted, the
proponent will be asked to submit a full application.
See the Request for Proposals document for instructions on
submitting a full proposal and fill out the
Application Form.
-
Full proposals will be due by May 1.
Each applicant will be notified of receipt of the
application within two weeks of the deadline.
-
Results of each annual competition will
be announced each year on or around September 9th,
International FASD Day.
-
Successful applicants will be asked to
present their protocols and preliminary results at the FACE
Research Roundtable the following year, and upon completion
of the project, their final results a year later at the subsequent
roundtable.
-
Applicants should note that a second
installment of funding is conditional upon submission of a
progress report.
-
The research grants are selected
annually after a peer-review of applications by a
committee of reviewers.
Reviewers
2009
-
Dr. Gideon Koren,
Professor and Director Motherisk Program, (Chair)
-
Dr. James Brien, Professor of
Pharmacology, Queen’s University
-
Dr. Albert E. Chudley, President of Medical Staff, Section of Genetics and Metabolism, Health Sciences Centre, Winnipeg
-
Dr. Julianne Conry, Key Psychologist, Multidisciplinary FAS Team, Asante Centre, British Columbia
-
Dr. Doreen Matsui, Clinical Pharmacologist and Pediatrician, Children’s Hospital of Western Ontario
-
Dr. Jo Nanson, Clinical Psychologist,
University of Saskatchewan
|
|
